Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03645499 · ClinicalTrials.gov registry record · Phase 1
An Open-Label Study to Assess Safety
A Phase 1 study, sponsored by Sun Pharmaceutical Industries.
- Completed
- Registry status
- Phase 1
- Development phase
- 88
- Enrollment target
NCT03645499 is a Phase 1 study that has completed, run by Sun Pharmaceutical Industries. The registered enrollment target is 88 participants.
The verdict
NCT03645499, a Phase 1 study, has completed, sponsored by Sun Pharmaceutical Industries.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 88 participants
- Enrollment target
Study Summary
An Open-Label study to assess safety
Interventions
- DRUG Topical TA-102 A
- DRUG Topical TA-102 B
- DRUG Topical TA-102 C
- DRUG Topical TA-102 D
- DRUG Topical TA-102 E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2018-04-04 |
| Est. Completion | 2020-01-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03645499
The ClinicalTrials.gov registry entry for NCT03645499 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sun Pharmaceutical Industries, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Topical TA-102 A is the first listed.
NCT03645499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03645499 about?
NCT03645499 is a clinical study titled "An Open-Label Study to Assess Safety". An Open-Label study to assess safety
What is the current status of trial NCT03645499?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2018-04-04. Estimated completion is 2020-01-07.
What interventions are being tested in trial NCT03645499?
The interventions under investigation include: Topical TA-102 A (DRUG), Topical TA-102 B (DRUG), Topical TA-102 C (DRUG), Topical TA-102 D (DRUG), Topical TA-102 E (DRUG).
Who is sponsoring clinical trial NCT03645499?
This trial is sponsored by Sun Pharmaceutical Industries, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.